Colitis aggravated by Mrgprb2 knockout is associated with altered immune response, intestinal barrier function and gut microbiota

被引:3
作者
Shao, Ming [1 ,2 ]
Liu, Jingwen [1 ,2 ]
Luo, Hesheng [1 ,3 ]
机构
[1] Wuhan Univ, Dept Gastroenterol, Renmin Hosp, Wuhan, Peoples R China
[2] Hubei Key Lab Digest Dis, Dept Gastroenterol, Wuhan, Peoples R China
[3] Wuhan Univ, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China
关键词
gut microbiota; inflammatory cells; intestinal barrier; mast cells; mrgprb2; ulcerative colitis; MAST-CELL; ACTIVATION;
D O I
10.1113/EP090635
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
New FindingsWhat is the central question of this study?What is the role of mas-related G protein-coupled receptor X2 (MRGPRX2/Mrgprb2) in ulcerative colitis in relation to the intestinal flora, intestinal barrier and immune response?What is the main finding and its importance?Knockout of mouse Mrgprb2 aggravates dextran sulfate sodium (DSS)-induced colitis, which is associated with altered gut microbiota and immune response and disruption of the intestinal barrier. MRGPRB2 may have a protective effect on DSS-induced colitis. Ulcerative colitis (UC) is a chronic immune-related disease, and changes in the intestinal microbiota and damage to the intestinal barrier contribute to its pathogenesis. Mast cells (MCs) are widely distributed in the gastrointestinal tract and are thought to be related to the pathogenesis of UC. Human mas-related G protein-coupled receptor X2 (MRGPRX2) and its mouse homologue, Mrgprb2, are selectively expressed on MCs to recruit immune cells and modulate host defence against microbial infection. To investigate the role of Mrgprb2 in UC in mice, we compared the differences between Mrgprb2 knockout (b2KO) male mice and wild-type (WT) male mice with dextran sulfate sodium (DSS)-induced colitis in the severity of clinical symptoms, inflammatory cell infiltration, degree of intestinal barrier damage and composition of the intestinal flora. The results showed that weight loss, disease activity index score, colon shortening and colonic pathological damage were significantly increased in b2KO mice while MC activation, cytokine and chemokine secretion, and inflammatory cell infiltration were decreased. In addition, the abundance and diversity of the intestinal microbiota were reduced in b2KO mice. B2KO mice also exhibited a reduction of probiotics such as norank_f_Muribaculaceae and Lactobacillus and increase of harmful bacteria like Escherichia-Shigella. Intestinal mucosal barrier damage of b2KO mice was more severe than that of WT mice due to the attenuated expression of mucin-2 and occludin. These results demonstrated that MRGPRB2 may have a protective effect on DSS-induced colitis by altering the intestinal flora, participating in barrier repair and recruiting inflammatory cells to eliminate pathogens.
引用
收藏
页码:63 / 75
页数:13
相关论文
共 40 条
  • [1] Intestinal Mucosal Mast Cells: Key Modulators of Barrier Function and Homeostasis
    Albert-Bayo, Merce
    Paracuellos, Irene
    Gonzalez-Castro, Ana M.
    Rodriguez-Urrutia, Amanda
    Rodriguez-Lagunas, Maria J.
    Alonso-Cotoner, Carmen
    Santos, Javier
    Vicario, Maria
    [J]. CELLS, 2019, 8 (02)
  • [2] Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis
    Alipour, Misagh
    Zaidi, Deenaz
    Valcheva, Rosica
    Jovel, Juan
    Martinez, Ines
    Sergi, Consolato
    Walter, Jens
    Mason, Andrew L.
    Wong, Gane Ka-Shu
    Dieleman, Levinus A.
    Carroll, Matthew W.
    Huynh, Hien Q.
    Wine, Eytan
    [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 (04) : 462 - 471
  • [3] New developments in goblet cell mucus secretion and function
    Birchenough, G. M. H.
    Johansson, M. E. V.
    Gustafsson, J. K.
    Bergstrom, J. H.
    Hansson, G. C.
    [J]. MUCOSAL IMMUNOLOGY, 2015, 8 (04) : 712 - 719
  • [4] Positive and Negative Signals in Mast Cell Activation
    Bulfone-Paus, Silvia
    Nilsson, Gunnar
    Draber, Petr
    Blank, Ulrich
    Levi-Schaffer, Francesca
    [J]. TRENDS IN IMMUNOLOGY, 2017, 38 (09) : 657 - 667
  • [5] The Commensal Microbiota and Enteropathogens in the Pathogenesis of Inflammatory Bowel Diseases
    Chassaing, Benoit
    Darfeuille-Michaud, Arlette
    [J]. GASTROENTEROLOGY, 2011, 140 (06) : 1720 - U40
  • [6] Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target
    Chen, Ernie
    Chuang, Ling-Shiang
    Giri, Mamta
    Villaverde, Nicole
    Hsu, Nai-Yun
    Sabic, Ksenija
    Joshowitz, Sari
    Gettler, Kyle
    Nayar, Shikha
    Chai, Zhi
    Alter, Isaac L.
    Chasteau, Colleen C.
    Korie, Ujunwa M.
    Dzedzik, Siarhei
    Thin, Tin Htwe
    Jain, Aayushee
    Moscati, Arden
    Bongers, Gerardus
    Duerr, Richard H.
    Silverberg, Mark S.
    Brant, Steven R.
    Rioux, John D.
    Peter, Inga
    Schumm, L. Philip
    Haritunians, Talin
    McGovern, Dermot P.
    Itan, Yuval
    Cho, Judy H.
    [J]. GASTROENTEROLOGY, 2021, 160 (05) : 1709 - 1724
  • [7] COOPER HS, 1993, LAB INVEST, V69, P238
  • [8] Revisiting fibrosis in inflammatory bowel disease: the gut thickens
    D'Alessio, Silvia
    Ungaro, Federica
    Noviello, Daniele
    Lovisa, Sara
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2022, 19 (03) : 169 - 184
  • [9] Ulcerative colitis: Gut microbiota, immunopathogenesis and application of natural products in animal models
    de Paula do Nascimento, Roberto
    da Fonseca Machado, Ana Paula
    Galvez, Julio
    Betim Cazarin, Cinthia Bau
    Marostica Junior, Mario Roberto
    [J]. LIFE SCIENCES, 2020, 258
  • [10] Mast cells at the crossroads of microbiota and IBD
    De Zuani, Marco
    Dal Secco, Chiara
    Frossi, Barbara
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 (12) : 1929 - 1937